|

Pembrolizumab injection Clinical Trials

8 actively recruiting trials across 6 locations

Also known as: Bevacizumab, CISPLATIN, KEYTRUDA®, nivolumab, ipilimumab, atlizumab, pemetrexed

Other2 trials

Capecitabine Plus Pembrolizumab in Patients With Triple Negative Breast Cancer After Chemo-immunotherapy and Surgery
Phase 2
Pembrolizumab Plus Bevacizumab and Chemotherapy for ALK-rearranged NSCLC With Persistent 5'ALK
Phase 2

Birmingham, Alabama1 trial

Molecular Residual Disease (MRD) Guided Adjuvant ThErapy in Renal Cell Carcinoma (RCC)

University of Alabama at Birmingham

Phase 2

Chandler, Arizona1 trial

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

Clinical Study Site

Phase 3

Phoenix, Arizona1 trial

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients

Banner University Medical Center

Phase 3

Fountain Valley, California1 trial

Development and Analysis of a Stool Bank for Cancer Patients

Compassionate Care Research Group, Inc.

Irvine, California1 trial

Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer

University of California, Irvine

Phase 1/2

Dallas, Texas1 trial

A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors

NEXT Oncology, Dallas

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.